Evolutionary Genomics Total Current Liabilities

Evolutionary Genomics posts a total current liabilities of $180K as of December 2022. That compares with $19K in the prior-year period — up 844.8% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Evolutionary Genomics's total current liabilities was $19K. The latest reading is $180K — a 844.8% year-over-year increase (period ending December 2022). Use the history and growth charts on this page for a longer lookback.

Total Current Liabilities is one piece of Evolutionary Genomics's financial statement story. At $180K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for FNAM's total current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Evolutionary Genomics's other metric pages and overview cover the third.

Judging Evolutionary Genomics against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in total current liabilities easier to interpret. Start with $180K here, then scan peer and history charts to see if the gap is persistent.